DaVita Inc. (DVA) Leadership & Management Team Analysis - Simply Wall St (2024)

Management criteria checks 3/4

DaVita's CEO is Javier Rodriguez, appointed in Jun 2019, has a tenure of 4.92 years. total yearly compensation is $6.71M, comprised of 21% salary and 79% bonuses, including company stock and options. directly owns 0.8% of the company’s shares, worth $98.42M. The average tenure of the management team and the board of directors is 4.9 years and 4.9 years respectively.

Key information

Javier Rodriguez

Chief executive officer

US$6.7m

Total compensation

CEO salary percentage21.0%
CEO tenure4.9yrs
CEO ownership0.8%
Management average tenure4.9yrs
Board average tenure4.9yrs

Recent management updates

Recent updates

DaVita Stock Is A Hold As It Expands In Latin America Mar 18Market Might Still Lack Some Conviction On DaVita Inc. (NYSE:DVA) Even After 27% Share Price BoostMar 13Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?Mar 04DaVita Inc. (NYSE:DVA) Analysts Are Pretty Bullish On The Stock After Recent ResultsFeb 16Is DaVita (NYSE:DVA) Using Too Much Debt?Feb 08DaVita: Assessing After The Rally Dec 29DaVita Inc.'s (NYSE:DVA) Subdued P/E Might Signal An OpportunityDec 24DaVita (NYSE:DVA) Has A Somewhat Strained Balance SheetNov 08DaVita: Simple And Compelling After Sell-Off Oct 26Returns On Capital Signal Difficult Times Ahead For DaVita (NYSE:DVA)Oct 25DaVita: Continued Economic Hurdles, Market Expectations May Be Correct Oct 05Is It Too Late To Consider Buying DaVita Inc. (NYSE:DVA)?Aug 14DaVita (NYSE:DVA) Takes On Some Risk With Its Use Of DebtJul 31DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold Jul 21Returns At DaVita (NYSE:DVA) Appear To Be Weighed DownJul 18DaVita Inc. (NYSE:DVA) Shares Could Be 41% Below Their Intrinsic Value EstimateJul 03What Is DaVita Inc.'s (NYSE:DVA) Share Price Doing?May 01These 4 Measures Indicate That DaVita (NYSE:DVA) Is Using Debt ExtensivelyApr 17Investors Met With Slowing Returns on Capital At DaVita (NYSE:DVA)Apr 03Are Investors Undervaluing DaVita Inc. (NYSE:DVA) By 40%?Mar 08DaVita HealthCare Partners Q4 2022 Earnings Preview Feb 21Moon Capital - DaVita: A Recession-Resistant Cash Generating Machine Feb 08Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?Jan 24Is DaVita (NYSE:DVA) A Risky Investment?Jan 09DaVita: Shares Still Appear Cheap After Outlook Cut, Technicals Suggest Caution Dec 12DaVita Q3 2022 Earnings Preview Oct 27Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?Oct 18DaVita: Solid Valuation And Cash Flow, Price Recovering After SCOTUS Ruling Sep 28DaVita could benefit from legislation that would return dialysis protection to Medicare Aug 16We Think DaVita (NYSE:DVA) Is Taking Some Risk With Its DebtAug 14DaVita stock dips as peer Fresenius outlook weighed down by labor cost, inflation Jul 28DaVita: Valuation Turning Attractive Jul 16Is It Too Late To Consider Buying DaVita Inc. (NYSE:DVA)?Jul 13Here's Why I Think DaVita (NYSE:DVA) Is An Interesting StockMay 15DaVita Offers Stability During Market Volatility May 12Here's Why DaVita (NYSE:DVA) Has A Meaningful Debt BurdenApr 29Is It Time To Consider Buying DaVita Inc. (NYSE:DVA)?Apr 14

CEO Compensation Analysis

How has Javier Rodriguez's remuneration changed compared to DaVita's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

US$816m

Dec 31 2023US$7mUS$1m

US$692m

Sep 30 2023n/an/a

US$596m

Jun 30 2023n/an/a

US$454m

Mar 31 2023n/an/a

US$500m

Dec 31 2022US$3mUS$1m

US$547m

Sep 30 2022n/an/a

US$680m

Jun 30 2022n/an/a

US$834m

Mar 31 2022n/an/a

US$903m

Dec 31 2021US$3mUS$1m

US$978m

Sep 30 2021n/an/a

US$984m

Jun 30 2021n/an/a

US$883m

Mar 31 2021n/an/a

US$791m

Dec 31 2020US$73mUS$1m

US$783m

Sep 30 2020n/an/a

US$832m

Jun 30 2020n/an/a

US$824m

Mar 31 2020n/an/a

US$816m

Dec 31 2019US$17mUS$1m

US$705m

Sep 30 2019n/an/a

US$623m

Jun 30 2019n/an/a

US$548m

Mar 31 2019n/an/a

US$551m

Dec 31 2018US$8mUS$900k

US$616m

Sep 30 2018n/an/a

US$617m

Jun 30 2018n/an/a

US$698m

Mar 31 2018n/an/a

US$652m

Dec 31 2017US$8mUS$900k

US$909m

Compensation vs Market: Javier's total compensation ($USD6.71M) is below average for companies of similar size in the US market ($USD13.58M).

Compensation vs Earnings: Javier's compensation has increased by more than 20% in the past year.

CEO

Javier Rodriguez (52 yo)

4.9yrs

Tenure

US$6,712,328

Compensation

Mr. Javier J. Rodriguez serves as an Independent Director at Gilead Sciences, Inc. since June 15, 2020. He has been Chief Executive Officer and Executive Director of DaVita Inc. since June 1, 2019. Mr. Rod...

Leadership Team

NamePositionTenureCompensationOwnership
Javier Rodriguez
CEO & Executive Director4.9yrsUS$6.71m0.80%
$ 98.4m
Joel Ackerman
CFO & Treasurer7.3yrsUS$6.87m0.16%
$ 19.7m
Kathleen Waters
Chief Legal & Public Affairs Officer8yrsUS$5.61m0.068%
$ 8.3m
James Hearty
Chief Compliance Officer6.2yrsUS$2.73m0.014%
$ 1.7m
Michael Staffieri
Chief Operating Officer of Kidney Care10.2yrsUS$10.42m0.23%
$ 28.2m
Christopher Berry
Group VP & Chief Accounting Officerless than a yearno datano data
Misha Palecek
Chief Transformation Officer of U.S. Kidney Care Businessno datano datano data
Jeffrey Giullian
Chief Medical Officer of Kidney Care4.3yrsno datano data
Partha Das
Chief Medical Officer of DaVita International5.8yrsno datano data
Mandy Hale
Chief Nursing Officer3.9yrsno datano data
Tina Livaudais
Chief Nursing Officer2.7yrsno datano data
Mihran Naljayan
Chief Medical Officer of Home Modalities & Pediatrics2.3yrsno datano data

4.9yrs

Average Tenure

53yo

Average Age

Experienced Management: DVA's management team is considered experienced (4.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Javier Rodriguez
CEO & Executive Director4.9yrsUS$6.71m0.80%
$ 98.4m
John Nehra
Independent Director23.5yrsUS$344.96k0.089%
$ 10.9m
Charles Berg
Director17.2yrsUS$322.46k0.029%
$ 3.5m
Barbara Desoer
Independent Director8.6yrsUS$384.96k0.012%
$ 1.5m
Phyllis Yale
Independent Director7.8yrsUS$374.96k0.017%
$ 2.1m
Wendy Schoppert
Independent Directorless than a yearUS$106.86k0.00093%
$ 114.0k
Pamela Arway
Independent Chair15yrsUS$497.46k0.027%
$ 3.3m
Dennis Pullin
Independent Directorless than a yearno datano data
Adam Schechter
Independent Director1.7yrsUS$334.96k0.0030%
$ 366.7k
Jason Hollar
Independent Director2yrsUS$364.96k0.0040%
$ 494.2k
Gregory Moore
Independent Director2.7yrsUS$355.89k0.0054%
$ 663.4k

4.9yrs

Average Tenure

63yo

Average Age

Experienced Board: DVA's board of directors are considered experienced (4.9 years average tenure).

DaVita Inc. (DVA) Leadership & Management Team Analysis  - Simply Wall St (2024)
Top Articles
Latest Posts
Article information

Author: Gov. Deandrea McKenzie

Last Updated:

Views: 5997

Rating: 4.6 / 5 (66 voted)

Reviews: 81% of readers found this page helpful

Author information

Name: Gov. Deandrea McKenzie

Birthday: 2001-01-17

Address: Suite 769 2454 Marsha Coves, Debbieton, MS 95002

Phone: +813077629322

Job: Real-Estate Executive

Hobby: Archery, Metal detecting, Kitesurfing, Genealogy, Kitesurfing, Calligraphy, Roller skating

Introduction: My name is Gov. Deandrea McKenzie, I am a spotless, clean, glamorous, sparkling, adventurous, nice, brainy person who loves writing and wants to share my knowledge and understanding with you.